Literature DB >> 20410308

Y65C missense mutation in the WW domain of the Golabi-Ito-Hall syndrome protein PQBP1 affects its binding activity and deregulates pre-mRNA splicing.

Victor E Tapia1, Emilia Nicolaescu, Caleb B McDonald, Valeria Musi, Tsutomu Oka, Yujin Inayoshi, Adam C Satteson, Virginia Mazack, Jasper Humbert, Christian J Gaffney, Monique Beullens, Charles E Schwartz, Christiane Landgraf, Rudolf Volkmer, Annalisa Pastore, Amjad Farooq, Mathieu Bollen, Marius Sudol.   

Abstract

The PQBP1 (polyglutamine tract-binding protein 1) gene encodes a nuclear protein that regulates pre-mRNA splicing and transcription. Mutations in the PQBP1 gene were reported in several X chromosome-linked mental retardation disorders including Golabi-Ito-Hall syndrome. The missense mutation that causes this syndrome is unique among other PQBP1 mutations reported to date because it maps within a functional domain of PQBP1, known as the WW domain. The mutation substitutes tyrosine 65 with cysteine and is located within the conserved core of aromatic amino acids of the domain. We show here that the binding property of the Y65C-mutated WW domain and the full-length mutant protein toward its cognate proline-rich ligands was diminished. Furthermore, in Golabi-Ito-Hall-derived lymphoblasts we showed that the complex between PQBP1-Y65C and WBP11 (WW domain-binding protein 11) splicing factor was compromised. In these cells a substantial decrease in pre-mRNA splicing efficiency was detected. Our study points to the critical role of the WW domain in the function of the PQBP1 protein and provides an insight into the molecular mechanism that underlies the X chromosome-linked mental retardation entities classified globally as Renpenning syndrome.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20410308      PMCID: PMC2885219          DOI: 10.1074/jbc.M109.084525

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  58 in total

1.  Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties.

Authors:  W G Kaelin; W Krek; W R Sellers; J A DeCaprio; F Ajchenbaum; C S Fuchs; T Chittenden; Y Li; P J Farnham; M A Blanar
Journal:  Cell       Date:  1992-07-24       Impact factor: 41.582

2.  Characterization of the WW domain of human yes-associated protein and its polyproline-containing ligands.

Authors:  H I Chen; A Einbond; S J Kwak; H Linn; E Koepf; S Peterson; J W Kelly; M Sudol
Journal:  J Biol Chem       Date:  1997-07-04       Impact factor: 5.157

3.  Sequence logos: a new way to display consensus sequences.

Authors:  T D Schneider; R M Stephens
Journal:  Nucleic Acids Res       Date:  1990-10-25       Impact factor: 16.971

4.  Interaction of WW domains with hematopoietic transcription factor p45/NF-E2 and RNA polymerase II.

Authors:  N R Gavva; R Gavva; K Ermekova; M Sudol; C J Shen
Journal:  J Biol Chem       Date:  1997-09-26       Impact factor: 5.157

5.  Rapid measurement of binding constants and heats of binding using a new titration calorimeter.

Authors:  T Wiseman; S Williston; J F Brandts; L N Lin
Journal:  Anal Biochem       Date:  1989-05-15       Impact factor: 3.365

6.  The WW domain: a signalling site in dystrophin?

Authors:  P Bork; M Sudol
Journal:  Trends Biochem Sci       Date:  1994-12       Impact factor: 13.807

7.  Npw38, a novel nuclear protein possessing a WW domain capable of activating basal transcription.

Authors:  A Komuro; M Saeki; S Kato
Journal:  Nucleic Acids Res       Date:  1999-05-01       Impact factor: 16.971

8.  The WW domain of Yes-associated protein binds a proline-rich ligand that differs from the consensus established for Src homology 3-binding modules.

Authors:  H I Chen; M Sudol
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

9.  Genotype-phenotype studies in three families with mutations in the polyglutamine-binding protein 1 gene (PQBP1).

Authors:  T Kleefstra; C E Franken; Y H J M Arens; G J A Ramakers; H G Yntema; E A Sistermans; C F C H Hulsmans; W N Nillesen; H van Bokhoven; B B A de Vries; B C J Hamel
Journal:  Clin Genet       Date:  2004-10       Impact factor: 4.438

10.  PQBP-1 transgenic mice show a late-onset motor neuron disease-like phenotype.

Authors:  Tomohiro Okuda; Hiroshi Hattori; Sousuke Takeuchi; Jun Shimizu; Hiroko Ueda; Jorma J Palvimo; Ichiro Kanazawa; Hitoshi Kawano; Masaya Nakagawa; Hitoshi Okazawa
Journal:  Hum Mol Genet       Date:  2003-04-01       Impact factor: 6.150

View more
  28 in total

1.  The XLID protein PQBP1 and the GTPase Dynamin 2 define a signaling link that orchestrates ciliary morphogenesis in postmitotic neurons.

Authors:  Yoshiho Ikeuchi; Luis de la Torre-Ubieta; Takahiko Matsuda; Hanno Steen; Hitoshi Okazawa; Azad Bonni
Journal:  Cell Rep       Date:  2013-08-29       Impact factor: 9.423

2.  A screen for conditional growth suppressor genes identifies the Drosophila homolog of HD-PTP as a regulator of the oncoprotein Yorkie.

Authors:  M Melissa Gilbert; Marla Tipping; Alexey Veraksa; Kenneth H Moberg
Journal:  Dev Cell       Date:  2011-05-17       Impact factor: 12.270

3.  A Proteomic Connectivity Map for Characterizing the Tumor Adaptive Response to Small Molecule Chemical Perturbagens.

Authors:  Zhenzhen Zi; Yajie Zhang; Peng Zhang; Qing Ding; Michael Chu; Yiwen Chen; John D Minna; Yonghao Yu
Journal:  ACS Chem Biol       Date:  2020-01-03       Impact factor: 5.100

Review 4.  Structures of YAP protein domains reveal promising targets for development of new cancer drugs.

Authors:  Marius Sudol; Denis C Shields; Amjad Farooq
Journal:  Semin Cell Dev Biol       Date:  2012-05-17       Impact factor: 7.727

Review 5.  Peptide-based Interaction Proteomics.

Authors:  Katrina Meyer; Matthias Selbach
Journal:  Mol Cell Proteomics       Date:  2020-04-28       Impact factor: 5.911

6.  Solution model of the intrinsically disordered polyglutamine tract-binding protein-1.

Authors:  Martin Rees; Christian Gorba; Cesira de Chiara; Tam T T Bui; Mitla Garcia-Maya; Alex F Drake; Hitoshi Okazawa; Annalisa Pastore; Dmitri Svergun; Yu Wai Chen
Journal:  Biophys J       Date:  2012-04-03       Impact factor: 4.033

Review 7.  Molecular insights into the WW domain of the Golabi-Ito-Hall syndrome protein PQBP1.

Authors:  Marius Sudol; Caleb B McDonald; Amjad Farooq
Journal:  FEBS Lett       Date:  2012-03-28       Impact factor: 4.124

8.  Genome-wide analysis of the WW domain-containing protein genes in silkworm and their expansion in eukaryotes.

Authors:  Gang Meng; Fangyin Dai; Xiaoling Tong; Niannian Li; Xin Ding; Jiangbo Song; Cheng Lu
Journal:  Mol Genet Genomics       Date:  2014-11-26       Impact factor: 3.291

9.  Biophysical basis of the binding of WWOX tumor suppressor to WBP1 and WBP2 adaptors.

Authors:  Caleb B McDonald; Laura Buffa; Tomer Bar-Mag; Zaidoun Salah; Vikas Bhat; David C Mikles; Brian J Deegan; Kenneth L Seldeen; Arun Malhotra; Marius Sudol; Rami I Aqeilan; Zafar Nawaz; Amjad Farooq
Journal:  J Mol Biol       Date:  2012-05-23       Impact factor: 5.469

10.  The tumour suppressor gene WWOX is mutated in autosomal recessive cerebellar ataxia with epilepsy and mental retardation.

Authors:  Martial Mallaret; Matthis Synofzik; Jaeho Lee; Cari A Sagum; Muhammad Mahajnah; Rajech Sharkia; Nathalie Drouot; Mathilde Renaud; Fabrice A C Klein; Mathieu Anheim; Christine Tranchant; Cyril Mignot; Jean-Louis Mandel; Mark Bedford; Peter Bauer; Mustafa A Salih; Rebecca Schüle; Ludger Schöls; C Marcelo Aldaz; Michel Koenig
Journal:  Brain       Date:  2013-12-24       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.